Transfer of ADAMTS13 antibodies-mediated thrombotic thrombocytopenic purpura via kidney transplantation

Thrombotic thrombocytopenic purpura (TTP) is a rare (annual prevalence ~10 cases per million people), relapsing and life-threatening thrombotic microangiopathy (TMA).[1][1],[2][2] Acute TTP is defined by a mechanical hemolytic anemia, severe thrombocytopenia and systemic visceral ischemia causing